Good morning :)
Place Order
Add to Watchlist

Eiko Lifesciences Ltd

EIKO Share Price

50.250.59% (-0.30)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹69 cr, stock is ranked 3,452

Stock is 4.27x as volatile as Nifty

EIKO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹69 cr, stock is ranked 3,452

Stock is 4.27x as volatile as Nifty

EIKO Performance & Key Metrics

EIKO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
20.251.22
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
27.913.181.62%

EIKO Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

EIKO Company Profile

Eiko LifeSciences Ltd specializes in manufacturing specialty and fine chemicals, including pharma intermediates and cosmetic ingredients, catering to diverse industrial needs.

EIKO Similar Stocks (Peers)

Compare with peers Compare with peers 

EIKO Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
68.09
68.09
1Y Return
20.57%
20.57%
Buy Reco %
63.64
63.64
PE Ratio
102.49
102.49
1Y Return
60.47%
60.47%
Buy Reco %
69.57
69.57
PE Ratio
40.58
40.58
1Y Return
14.99%
14.99%
Buy Reco %
75.00
75.00
PE Ratio
37.25
37.25
1Y Return
3.71%
3.71%
Buy Reco %
100.00
100.00
PE Ratio
153.86
153.86
1Y Return
70.75%
70.75%
Buy Reco %
42.86
42.86
Compare with Peers

EIKO Forecast

EIKO Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

EIKO

EIKO

Income

Balance Sheet

Cash Flow

EIKO Income Statement

EIKO Income Statement

Loading...

Financial YearFY 2025TTM
Total Revenue38.8642.37
Raw Materialssubtract35.0435.92
Power & Fuel Costsubtract0.19
Employee Costsubtract0.35
Selling & Administrative Expensessubtract0.32
Operating & Other expensessubtract-1.00
Depreciation/Amortizationsubtract0.740.92
Interest & Other Itemssubtract0.170.25
Taxes & Other Itemssubtract0.751.84
EPS1.662.48
DPS0.000.00
Payout ratio0.000.00

EIKO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Jul 30PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

Apr 20PDF
Feb 10PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

EIKO Stock Peers

EIKO Past Performance & Peer Comparison

EIKO Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Eiko Lifesciences Ltd30.281.22
Gujarat Fluorochemicals Ltd68.095.090.09%
Navin Fluorine International Ltd102.4911.260.12%
Vinati Organics Ltd40.585.890.47%

EIKO Stock Price Comparison

Compare EIKO with any stock or ETF
Compare EIKO with any stock or ETF
EIKO
Loading...

EIKO Holdings

EIKO Shareholdings

EIKO Promoter Holdings Trend

EIKO Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

EIKO Institutional Holdings Trend

EIKO Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

EIKO Shareholding Pattern

EIKO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding37.17%0.00%0.00%0.00%62.83%

Mar 2025

Jun 2025

Aug 2025

Sep 2025

EIKO Shareholding History

EIKO Shareholding History

Dec '24JanMarJunAugSep0.00%0.00%0.00%0.00%0.00%0.00%

EIKO Insider Trades & Bulk Stock Deals

EIKO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing EIKO stock

smallcases containing EIKO stock

Looks like this stock is not in any smallcase yet.

EIKO Events

EIKO Events

EIKO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

EIKO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

EIKO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

EIKO has not given any dividends in last 5 years

EIKO Upcoming Dividends

EIKO Upcoming Dividends

No upcoming dividends are available

EIKO Past Dividends

EIKO Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2017

Final
Final | Div/Share: ₹0.25

Dividend/Share

0.25

Ex DateEx Date

Sep 20, 2017

EIKO Stock News & Opinions

EIKO Stock News & Opinions

Earnings
Eiko Lifesciences standalone net profit rises 290.48% in the September 2025 quarter

Net profit of Eiko Lifesciences rose 290.48% to Rs 0.82 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. Sales rose 18.86% to Rs 9.20 crore in the quarter ended September 2025 as against Rs 7.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales9.207.74 19 OPM %7.934.65 - PBDT1.220.45 171 PBT1.070.29 269 NP0.820.21 290 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Eiko Lifesciences to hold board meeting

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Eiko Lifesciences to hold AGM

Eiko Lifesciences announced that the 48th Annual General Meeting(AGM) of the company will be held on 5 September 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 97.14% in the June 2025 quarter

Net profit of Eiko Lifesciences rose 97.14% to Rs 0.69 crore in the quarter ended June 2025 as against Rs 0.35 crore during the previous quarter ended June 2024. Sales declined 30.70% to Rs 7.45 crore in the quarter ended June 2025 as against Rs 10.75 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales7.4510.75 -31 OPM %7.113.81 - PBDT1.060.64 66 PBT0.910.47 94 NP0.690.35 97 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Eiko Lifesciences to discuss results

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 190.32% in the March 2025 quarter

Net profit of Eiko Lifesciences rose 190.32% to Rs 0.90 crore in the quarter ended March 2025 as against Rs 0.31 crore during the previous quarter ended March 2024. Sales declined 15.60% to Rs 7.09 crore in the quarter ended March 2025 as against Rs 8.40 crore during the previous quarter ended March 2024. For the full year,net profit rose 132.00% to Rs 1.74 crore in the year ended March 2025 as against Rs 0.75 crore during the previous year ended March 2024. Sales rose 16.33% to Rs 32.49 crore in the year ended March 2025 as against Rs 27.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales7.098.40 -16 32.4927.93 16 OPM %7.336.07 -5.235.73 - PBDT1.010.60 68 2.601.64 59 PBT0.860.42 105 1.970.98 101 NP0.900.31 190 1.740.75 132 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Eiko Lifesciences to hold board meeting

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Eiko Lifesciences to announce Quarterly Result

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 16.67% in the December 2024 quarter

Net profit of Eiko Lifesciences rose 16.67% to Rs 0.28 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 4.54% to Rs 6.91 crore in the quarter ended December 2024 as against Rs 6.61 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales6.916.61 5 OPM %6.517.11 - PBDT0.530.45 18 PBT0.380.29 31 NP0.280.24 17 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Eiko Lifesciences to discuss results

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Eiko Lifesciences Ltd (EIKO) today?

    The share price of EIKO as on 5th December 2025 is ₹50.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Eiko Lifesciences Ltd (EIKO) share?

    The past returns of Eiko Lifesciences Ltd (EIKO) share are
    • Past 1 week: -0.45%
    • Past 1 month: -20.98%
    • Past 3 months: -0.72%
    • Past 6 months: 1.52%
    • Past 1 year: -14.29%
    • Past 3 years: 33.58%
    • Past 5 years: 95.23%

  3. What are the peers or stocks similar to Eiko Lifesciences Ltd (EIKO)?
  4. What is the market cap of Eiko Lifesciences Ltd (EIKO) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd (EIKO) is ₹69.65 Cr as of 5th December 2025.

  5. What is the 52 week high and low of Eiko Lifesciences Ltd (EIKO) share?

    The 52-week high of Eiko Lifesciences Ltd (EIKO) is ₹74.88 and the 52-week low is ₹42.

  6. What is the PE and PB ratio of Eiko Lifesciences Ltd (EIKO) stock?

    The P/E (price-to-earnings) ratio of Eiko Lifesciences Ltd (EIKO) is 30.28. The P/B (price-to-book) ratio is 1.22.

  7. Which sector does Eiko Lifesciences Ltd (EIKO) belong to?

    Eiko Lifesciences Ltd (EIKO) belongs to the Materials sector & Specialty Chemicals sub-sector.

  8. How to buy Eiko Lifesciences Ltd (EIKO) shares?

    You can directly buy Eiko Lifesciences Ltd (EIKO) shares on Tickertape. Simply sign up, connect your demat account and place your order.